These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 12419589
21. Malignant pleural mesothelioma in Turkey, 2000-2002. Emri S, Demir AU. Lung Cancer; 2004 Aug; 45 Suppl 1():S17-20. PubMed ID: 15261427 [Abstract] [Full Text] [Related]
26. del(6q) as a possible primary change in malignant mesothelioma. Meloni AM, Stephenson CF, Li FP, Sandberg AA. Cancer Genet Cytogenet; 1992 Mar 04; 59(1):57-61. PubMed ID: 1555192 [Abstract] [Full Text] [Related]
27. Malignant mesothelioma: attributable risk of asbestos exposure. Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J. Occup Environ Med; 1994 Dec 04; 51(12):804-11. PubMed ID: 7849863 [Abstract] [Full Text] [Related]
32. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Matsumoto S, Nabeshima K, Kamei T, Hiroshima K, Kawahara K, Hata S, Marukawa K, Matsuno Y, Taguchi K, Tsujimura T. Cancer Cytopathol; 2013 Aug 04; 121(8):415-22. PubMed ID: 23450849 [Abstract] [Full Text] [Related]
33. [Massive exposure to asbestos and malignant mesothelioma, familial accumulation]. Otte KE, Sigsgaard TI, Kjaerulff J. Ugeskr Laeger; 1990 Oct 08; 152(41):3013-4. PubMed ID: 2173188 [Abstract] [Full Text] [Related]
34. Clinical, histologic, and genetic features of mesothelioma in a 7-year-old child. Sugalski A, Davis M, Prasannan L, Saldivar V, Hung JY, Tomlinson GE. Pediatr Blood Cancer; 2013 Jan 08; 60(1):146-8. PubMed ID: 22961710 [Abstract] [Full Text] [Related]
35. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Ann Intern Med; 1982 Jun 08; 96(6 Pt 1):746-55. PubMed ID: 7091938 [Abstract] [Full Text] [Related]
36. [Evaluation of 15 malignant mesothelioma patients from the aspect of clinical findings and pathology--relationship between asbestos and malignant mesothelioma]. Kishimoto T, Ono T, Okada K. Nihon Naika Gakkai Zasshi; 1987 Apr 08; 76(4):586-7. PubMed ID: 3611919 [No Abstract] [Full Text] [Related]
37. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR. Cancer Res; 1993 Sep 15; 53(18):4349-55. PubMed ID: 8364929 [Abstract] [Full Text] [Related]
38. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Neri M, Filiberti R, Taioli E, Garte S, Paracchini V, Bolognesi C, Canessa PA, Fontana V, Ivaldi GP, Verna A, Bonassi S, Puntoni R. Mutat Res; 2005 Dec 30; 592(1-2):36-44. PubMed ID: 15993904 [Abstract] [Full Text] [Related]
39. Differences among peritoneal and pleural mesothelioma: data from the Lombardy Region Mesothelioma Register (Italy). Mensi C, Bonzini M, Macchione M, Sieno C, Riboldi L, Pesatori AC. Med Lav; 2011 Dec 30; 102(5):409-16. PubMed ID: 22022760 [Abstract] [Full Text] [Related]
40. Case report: malignant peritoneal mesothelioma in two siblings. Picklesimer AH, Zanagnolo V, Niemann TH, Eaton LA, Copeland LJ. Gynecol Oncol; 2005 Nov 30; 99(2):512-6. PubMed ID: 16051325 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]